These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7742486)

  • 1. Adenosine, added to St Thomas' Hospital cardioplegic solution, improves functional recovery and reduces irreversible myocardial damage.
    van der Lee C; Huizer T; Janssen M; Tavenier M; Stassen EJ; Arad M; de Jong JW
    Cardioscience; 1994 Dec; 5(4):269-75. PubMed ID: 7742486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient hypocalcemic reperfusion does not improve postischemic recovery in the rat heart after preservation with St. Thomas' Hospital cardioplegic solution.
    Chambers DJ; Harvey DM; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1992 Aug; 104(2):344-56. PubMed ID: 1495296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term preservation of the heart: the effect of infusion pressure during continuous hypothermic cardioplegia.
    Chambers DJ; Takahashi A; Hearse DJ
    J Heart Lung Transplant; 1992; 11(4 Pt 1):665-75. PubMed ID: 1498129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart.
    Kempsford RD; Hearse DJ
    J Thorac Cardiovasc Surg; 1989 Jun; 97(6):856-63. PubMed ID: 2498580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous adenosine accelerates recovery of cardiac function and improves coronary flow after long-term hypothermic storage and transplantation.
    Galiñanes M; Hearse DJ
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):151-8. PubMed ID: 1614201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowering the calcium concentration in St. Thomas' Hospital cardioplegic solution improves protection during hypothermic ischemia.
    Robinson LA; Harwood DL
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):314-25. PubMed ID: 1992242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of the chronic hypoxic immature rat heart during global ischemia.
    Karck M; Ziemer G; Zoeller M; Schulte S; Juergens KD; Weisser H; Haverich A
    Ann Thorac Surg; 1995 Mar; 59(3):699-706. PubMed ID: 7887715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of low coronary reflow improves postischemic myocardial function.
    Amrani M; Shirvani R; Allen NJ; Ledingham S; Yacoub MH
    J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1375-82. PubMed ID: 1434719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of L-arginine on myocardial recovery after cardioplegic arrest and ischemia under moderate and deep hypothermia.
    Amrani M; Gray CC; Smolenski RT; Goodwin AT; London A; Yacoub MH
    Circulation; 1997 Nov; 96(9 Suppl):II-274-9. PubMed ID: 9386110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved myocardial protection by oxygenation of St. Thomas' Hospital cardioplegic solutions. Studies in the rat.
    Ledingham SJ; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1988 Jan; 95(1):103-11. PubMed ID: 3336223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution.
    Yang SS; Hearse DJ
    Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion.
    Takahashi A; Chambers DJ; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1988 Nov; 96(5):730-40. PubMed ID: 3184967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonists and myocardial protection: a comparative study of the functional, metabolic and electrical consequences of verapamil and nifedipine as additives to the St. Thomas' cardioplegic solution.
    Yamamoto F; Manning AS; Crome R; Braimbridge MV; Hearse DJ
    Thorac Cardiovasc Surg; 1985 Dec; 33(6):354-9. PubMed ID: 2417372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced myocardial protection with high-energy phosphates in St. Thomas' Hospital cardioplegic solution. Synergism of adenosine triphosphate and creatine phosphate.
    Robinson LA; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1987 Mar; 93(3):415-27. PubMed ID: 3821150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of Na movement on surgical myocardial protection: the role of the Na+-H+ exchange system and Na-channel in the development of ischemia and reperfusion injury.
    Liu KX; Yamamoto F; Yamamoto H; Wang T; Zhu Z; Xu R; Zhang S
    Ann Thorac Cardiovasc Surg; 2007 Oct; 13(5):301-7. PubMed ID: 17954986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species differences in susceptibility to ischemic injury and responsiveness to myocardial protection.
    Galiñanes M; Hearse DJ
    Cardioscience; 1990 Jun; 1(2):127-43. PubMed ID: 2102801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dichloroacetate enhanced myocardial functional recovery post-ischemia : ATP and NADH recovery.
    Wahr JA; Olszanski D; Childs KF; Bolling SF
    J Surg Res; 1996 Jun; 63(1):220-4. PubMed ID: 8661201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of amino acids on the ischemic heart. Improvement of oxygenated crystalloid cardioplegic solution by an enriched branched chain amino acid formulation.
    Schwalb H; Izhar U; Yaroslavsky E; Borman JB; Uretzky G
    J Thorac Cardiovasc Surg; 1989 Oct; 98(4):551-6. PubMed ID: 2796362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.